鳞状细胞食管癌的根治性或新辅助放化疗？ - Suppr

Suppr

超能文献

Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?

作者信息

Ilson David, Lordick Florian

出版信息

Lancet Oncol. 2018 Oct;19(10):1285-1286. doi: 10.1016/S1470-2045(18)30662-4. Epub 2018 Oct 1.

DOI:10.1016/S1470-2045(18)30662-4

PMID:30528077

Abstract

摘要

相似文献

Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?鳞状细胞食管癌的根治性或新辅助放化疗？

Lancet Oncol. 2018 Oct;19(10):1285-1286. doi: 10.1016/S1470-2045(18)30662-4. Epub 2018 Oct 1.

Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.局部晚期食管癌的多学科治疗，特别提及手术转换与挽救治疗

Anticancer Res. 2019 Jun;39(6):3167-3175. doi: 10.21873/anticanres.13454.

Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.新辅助治疗对食管鳞癌患者术后并发症不良长期结局的影响：一项回顾性队列研究。

Ann Surg Oncol. 2019 Jul;26(7):2081-2089. doi: 10.1245/s10434-019-07312-z. Epub 2019 Apr 1.

Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?对于食管鳞状细胞癌患者，新辅助化疗联合免疫治疗真的比新辅助放化疗更好吗？

J Thorac Cardiovasc Surg. 2024 Aug;168(2):e31-e32. doi: 10.1016/j.jtcvs.2024.02.024. Epub 2024 Mar 27.

Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?新辅助放化疗反应者、无反应者以及接受局部晚期食管鳞状细胞癌原发切除术患者的生存比较：新辅助放化疗对所有患者都有益吗？

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):460-6. doi: 10.1093/icvts/ivt216. Epub 2013 May 31.

Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.新辅助化疗联合免疫疗法与新辅助放化疗治疗局部晚期食管鳞状细胞癌患者的疗效比较

J Thorac Cardiovasc Surg. 2024 Aug;168(2):417-428.e3. doi: 10.1016/j.jtcvs.2023.12.030. Epub 2024 Jan 19.

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.新辅助放化疗联合手术治疗食管鳞癌患者的复发模式和时间。

BMC Cancer. 2021 Nov 9;21(1):1192. doi: 10.1186/s12885-021-08918-x.

PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS.食管癌鳞状细胞癌新辅助化疗和放疗后行食管切除术后的病理完全缓解（ypT0 ypN0）

Arq Bras Cir Dig. 2018 Dec 6;31(4):e1405. doi: 10.1590/0102-672020180001e1405.

Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study.辅助放化疗联合帕博利珠单抗治疗新辅助放化疗后复发风险高的局部晚期食管鳞癌：一项单臂 II 期研究。

Cancer Immunol Immunother. 2024 Sep 9;73(11):230. doi: 10.1007/s00262-024-03826-y.

Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.内镜下切除黏膜下食管鳞癌后行食管切除术与放化疗的长期疗效比较。

Dis Esophagus. 2019 Dec 31;32(12). doi: 10.1093/dote/doz023.

引用本文的文献

The role of SEC14L4 in esophageal squamous cell cancer: insights into clinical relevance and molecular pathways.SEC14L4在食管鳞状细胞癌中的作用：对临床相关性和分子途径的见解。

Transl Cancer Res. 2024 Oct 31;13(10):5535-5549. doi: 10.21037/tcr-24-1657. Epub 2024 Oct 29.

HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.HMGA1 通过抑制铁死亡来驱动食管鳞癌的化疗耐药性。

Cell Death Dis. 2024 Feb 21;15(2):158. doi: 10.1038/s41419-024-06467-2.

Risk factors for anastomotic leakage after surgical resections for esophageal cancer.食管癌手术后吻合口漏的危险因素。

Langenbecks Arch Surg. 2021 Sep;406(6):1859-1866. doi: 10.1007/s00423-021-02139-3. Epub 2021 May 15.

Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment.食管癌耐药性研究进展：基于肿瘤微环境视角

Front Cell Dev Biol. 2021 Mar 19;9:664816. doi: 10.3389/fcell.2021.664816. eCollection 2021.

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.一种用于预测接受根治性放化疗的食管鳞状细胞癌患者生存情况的列线图。

Ann Transl Med. 2021 Feb;9(3):233. doi: 10.21037/atm-20-1460.

Matrix metalloproteinase-14 (MMP-14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation.基质金属蛋白酶-14（MMP-14）下调抑制食管鳞癌细胞迁移、侵袭和增殖。

Thorac Cancer. 2020 Nov;11(11):3168-3174. doi: 10.1111/1759-7714.13636. Epub 2020 Sep 15.

Role of linear endosonography in the diagnosis of biopsy-negative malignant esophageal strictures: Exploring the unexplored.线性内镜超声在活检阴性的恶性食管狭窄诊断中的作用：探索未被探索的领域。

JGH Open. 2019 Jul 18;4(2):113-116. doi: 10.1002/jgh3.12225. eCollection 2020 Apr.

Intratumoral Immunotherapy for Early-stage Solid Tumors.瘤内免疫治疗早期实体瘤。

Clin Cancer Res. 2020 Jul 1;26(13):3091-3099. doi: 10.1158/1078-0432.CCR-19-3642. Epub 2020 Feb 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验